Erasca, Inc.

ERAS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jan 30, 2026 4
4 Jan 30, 2026 4
4 Jan 30, 2026 4
4 Jan 30, 2026 4
8-K Jan 29, 2026 8-K
8-K Jan 22, 2026 8-K
424B5 Jan 22, 2026 424B5
8-K Jan 20, 2026 8-K
424B5 Jan 20, 2026 424B5
144 Jan 15, 2026
SCHEDULE 13G Jan 14, 2026
8-K Jan 12, 2026 8-K
4 Jan 8, 2026 4
144 Jan 7, 2026
4 Jan 5, 2026 4
4 Jan 5, 2026 4
4 Jan 5, 2026 4
4 Jan 5, 2026 4
4 Jan 5, 2026 4
144 Dec 15, 2025
144 Nov 17, 2025
SCHEDULE 13G/A Nov 14, 2025
10-Q Nov 12, 2025 10-Q
8-K Nov 12, 2025 8-K
144 Oct 15, 2025
← Newer Page 3 of 14 · 350 filings Older →